Evropska unija - estonščina - EMA (European Medicines Agency)

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, soole põletikuvastased / antiinfective ained - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.

Evropska unija - estonščina - EMA (European Medicines Agency)

ucb pharma sa - brivaracetam - epilepsia - antiepileptics, - briviact on näidustatud adjunctive ravi ravi osaline algusega krambid koos või ilma sekundaarse teha üldistusi täiskasvanud ja noorukieas patsientidel alates 16 aasta vanusest, kellel epilepsia.

Estonija - estonščina - Ravimiamet

novartis baltics sia - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 400mg 30tk

Estonija - estonščina - Ravimiamet

novartis baltics sia - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 200mg 50tk

Estonija - estonščina - Ravimiamet

teva pharma b.v. - karbamasepiin - tablett - 200mg 50tk

Estonija - estonščina - Ravimiamet

takeda pharma as - karbamasepiin - tablett - 200mg 50tk

Estonija - estonščina - Ravimiamet

teva pharma b.v. - karbamasepiin - toimeainet modifitseeritult vabastav tablett - 200mg 50tk

Estonija - estonščina - Ravimiamet

teva pharma b.v. - karbamasepiin - toimeainet modifitseeritult vabastav tablett - 400mg 50tk

Evropska unija - estonščina - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - idiopaatiline, trombotsütopeeniline purpur - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Estonija - estonščina - Ravimiamet

upjohn eesv - venlafaksiin - toimeainet prolongeeritult vabastav kõvakapsel - 75mg 84tk; 75mg 10tk; 75mg 100tk; 75mg 98tk; 75mg 28tk; 75mg 14tk; 75mg 500tk; 75mg 56tk